Initial and delayed onset of acute respiratory failure: Factors associated with development and outcome

Anesthesia and Analgesia

Volumn 103, Issue 5, 2006, Pages 1219-1223

  Lobo, Suzana M ^a   Lobo, Francisco R M ^a   Lopes Ferreira, Flavio ^a   Bota, Daliana Peres ^a   Melot, Christian ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ACUTE RESPIRATORY FAILURE; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OXYGEN TENSION; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, ADULT; TIME FACTORS; TREATMENT OUTCOME;

EID: 33750378026     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000237433.00877.5a     Document Type: Article

References (32)

1. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818-24.
2. Vasilyev S, Schaap RN, Mortensen JD. Hospital survival rates of patients with acute respiratory failure in modern respiratory intensive care units. An international, multicenter, prospective survey. Chest 1995;107:1083-8.
3. Luhr OR, Antonsen K, Karlsson M, et al; The ARF Study Group. Incidence and mortality after acute respiratory failure and acute respiratory distress syndrome in Sweden, Denmark, and Iceland. Am J Respir Crit Care Med 1999;159:1849-61.
4. Vincent JL, Akca S, de Mendonca A, et al. The epidemiology of acute respiratory failure in critically ill patients. Chest 2002;121:1602-9.
5. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004;292:2379-87.
6. Croce MA, Fabian TC, Davis KA, Gavin TJ. Early and late acute respiratory distress syndrome: two distinct clinical entities. J Trauma 1999;46:361-6.
7. Modig J, Hedstrand U, Wegenius G. Determinants of early adult respiratory distress syndrome. A retrospective study of 220 patients with major fractures. Acta Chir Scand 1985;151:413-8.
8. Rady MY, Ryan T, Starr NJ. Early onset of acute pulmonary dysfunction after cardiovascular surgery: risk factors and clinical outcome. Crit Care Med 1997;25:1831-9.
9. Guerin C, Girard R, Selli JM, et al.; Rhone-Alpes Area Study Group on acute renal failure. Initial versus delayed acute renal failure in the intensive care unit. A multicenter prospective epidemiological study. Am J Respir Crit Care Med 2000;161:872-9.
10. Lopes Ferreira F, Peres Bota D, et al. Serial evaluation of the SOFA score to predict outcome. JAMA 2001;286:1754-8.
11. Lobo SM, Lobo FR, Bota DP, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 2003;123:2043-9.
12. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
13. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicentric, prospective study. Crit Care Med 1998;26:1793-800.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
15. Póvoa P, Almeida E, Moreira P, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-6.
16. Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995;21:602-5.
17. Smith RP, Lipworth BJ, Cree IA, et al. C-reactive protein. A clinical marker in community-acquired pneumonia. Chest 1995;108:1288-91.
18. Abernathy VJ, Webster RO, Dahms TE. C-reactive protein inhibits increased pulmonary vascular permeability induced by fMLP in isolated rabbit lungs. Am J Physiol 1996;271:H507-13.
19. Heuertz RM, Webster RO. Role of C-reactive protein in acute lung injury. Mol Med Today 1997;3:539-45.
20. Casals C, Arias-Diaz J, Valino F, et al. Surfactant strengthens the inhibitory effect of C-reactive protein on human lung macrophage cytokine release. Am J Physiol Lung Cell Mol Physiol 2003;284:L466-72.
21. Ugarte H, Silva E, Mercan D, et al. Procalcitonin as a marker of infection in the intensive care unit. Crit Care Med 1999;27:498-504.
22. Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentration in patients with sepsis and infection. Lancet 1993;341:515-8.
23. Schweickert WD, Gehlbach BK, Pohlman AS, et al. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 2004;32:1272-6.
24. Ibanez J, Penafiel A, Marse P, et al. Incidence of gastroesophageal reflux and aspiration in mechanically ventilated patients using small-bore nasogastric tubes. JPEN J Parenter Enteral Nutr 2000;24:103-6.
25. Drakulovic MB, Torres A, Bauer TT, et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999;354:1851-8.
26. de Oliveira GG, Antonio MP. Role of the central nervous system in the adult respiratory distress syndrome. Crit Care Med 1987;15:844-9.
27. Dive A, Miesse C, Galanti L, et al. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 1995;23:1356-62.
28. Jimenez P, Torres A, Roca J, et al. Arterial oxygenation does not predict the outcome of patients with acute respiratory failure needing mechanical ventilation. Eur Respir J 1994;7:730-5.
29. Roupie E, Lepage E, Wysocki M, et al. Prevalence, etiologies and outcome of the acute respiratory distress syndrome among hypoxemic ventilated patients. Intensive Care Med 1999;25:920-9.
30. 2 ratio and its differential response to conventional therapy. Chest 1989;96:849-51.
31. Valta P, Uusaro A, Nunes S, et al. Acute respiratory distress syndrome: frequency, clinical course, and costs of care. Crit Care Med 1999;27:2367-74.
32. Flaatten H, Gjerde S, Guttormsen AB, et al. Outcome after acute respiratory failure is more dependent on dysfunction in other vital organs than on the severity of the respiratory failure. Crit Care 2003;7:R72-7.